key: cord-0009217-n1ah0ea6
authors: Haggard, Dale L.
title: Bovine Enteric Colibacillosis
date: 2016-02-15
journal: Vet Clin North Am Food Anim Pract
DOI: 10.1016/s0749-0720(15)31298-6
sha: a24a3a9c499dd0257f2209c80be752d3a358b009
doc_id: 9217
cord_uid: n1ah0ea6

In this article, the author discusses procedures used to determine enteropathogenic strains of Escherichia coli, the history of the development of prophylactic procedures, including cow vaccination and specific monoclonal antibody, and other preventative measures such as proper management, nutrition, and sanitation.

milk, or semisolid, and may be yellow-white or grey in color. Affected calves rapidly become dehydrated and lose weight. Depression, anorexia, and weakness follow. The rectal temperature is usually normal in the initial stages but becomes subnormal as the disease worsens. Affected calves die or recover in several days depending on the severity of the diarrhea and the therapy they receive. Death usually occurs in 3 to 5 days. lO Mild to moderately affected calves may be diarrheic for a few days and recover spontaneously with or without treatment. Those more severely affected become progressively worse over a period of several days, gradually become more weak, completely anorexic, and progressively more clinically dehydrated. The degree of dehydration will vary from 4 to 6 per cent of body weight (when it is just barely detectable clinically) to up to 10 to 16 per cent of body weight. Degree of hydration can be assessed by "tenting" the skin of the neck and measuring the time required for the skin fold to return to normal. In calves with 8 per cent dehydration, it will take 5 to 10 seconds for the skin fold to disappear; in calves with 10 to 12 per cent dehydration, it will take up to 30 seconds. 7 

Investigations of field cases of neonatal calf diarrhea have shown that infection with more than one enteropathogen occurring in different combinations is more common than infection with a single agent. 3 ,51 EPEC, rotavirus, coronavirus, and cryptosporidia are the enteropathogens most commonly encountered in field investigations. 76 It has been shown that infection with both EPEC and rotavirus can precipitate a disease in circumstances in which each agent acting independently may not. It is likely that there are many other combinatiohs that would induce a disease in calves, the severity of which may depend partly on noninfectious contributing factors and on the nature of the organisms involved. 5 

Morbidity in confined dairy calves may reach 75 per cent, but it is more commonly about 30 per cent. In beef calves, the morbidity will vary from 10 to 50 per cent in unvaccinated herds. The case fatality rate varies from 5 to 50 per cent, depending on management, observation, and therapy. 7

One or more infectious agents are involved in nearly all cases of neonatal calf scours. Infection of the intestine by these agents causes abnormal intestinal function, resulting in diarrhea, dehydration, electrolyte imbalance, acidosis, starvation, and sometimes death. 6 The following procedures are used in differential diagnosis.

Calves affected with enteric coli bacillosis are usually less than 1 week old. Rotavirus and coronavirus can affect calves from 1 day to 1 month of age. Cryptosporidia affects calves over 1 week of age. 6 Specimens for Laboratory Examination

The ideal specimen for submission to a diagnostic laboratory is a live, acutely ill, and untreated calf. If only dead calves are offered, they should be submitted as soon after death as possible. Tissues should be removed from the animal as soon as possible in field necropsy and should include the following: (1) sections of duodenum, jejunum, ileum, and colon flushed and fixed with formalin for histologic examination; (2) unfixed impression smears of ileal mucosa for fluorescent antibody (FA) test; (3) cecal fluid fixed with formalin for electron microscopic examination for virus and flotation for protozoa; (4) portions of chilled jejunum, ileum, and colon for FA tests for rotavirus and coronavirus, bacterial culture, and virus isolation.

The importance of having a necropsy performed as soon after death as possible cannot be overemphasized, because postmortem autolysis of the gastrointestinal tract occurs very rapidly. It is important that none of the materials be frozen. Freezing greatly diminishes their diagnostic value. 17 Identification of the K99 antigen by slide agglutination, enzyme-linked immunosorbent assay, electron microscopy, or fluorescent antibody testing is necessary to determine if the strain is enteropathogenic.

Blood counts and measurement of serum immunoglobulins may assist in making a diagnosis. 6

The significance of E. coli in the etiology of bovine enteric colibacillosis was first recorded in 1893. 35 Because E. coli could be isolated from the feces of both normal and diarrheic calves, a primary objective of investigations of enteric colibacillosis was to determine which E. coli isolates were pathogens and involved in clinical disease.

In 1897, the view was expressed that injured intestinal epithelium allowed invasion by ordinary colon bacilli, which by a few hours after birth are already in the intestinal canal. By giving a newborn calf a small dose of creolin water or pykotanin solution, a sev~re enteritis was produced and colon bacteria occurred in the blood and organs. 34

Strains of E. coli produce two types of colonies. Low-convex mucoid colonies are formed by capsulated bacteria and grey, translucent colonies are formed by noncapsulated organisms. Mutation from mucoid to grey occurs readily, indicating that the presence or absence of a capsule did not indicate enteropathogenicity.69

Isolates of enteropathogenic and nonenteropathogenic E. coli have been examined repeatedly over the decades using as many as 64 biochemical tests. These tests included fermentation of 30 different carbohydrates, hydrogen sulfide and indole production, methyl red and Voges-Proskauer reactions, litmus milk reaction, nitrate reduction, utilization of citrate and malonate, phenylalanine deamination, decarboxylation reactions on 15 amino acids, and production of amylase, catylase, lecithinase, lipase, protease, and urease. None of these tests were successful in differentiating pathogenic from nonpathogenic strains. 8 Serological Typing

Strains of E. coli are serologically identified by the types of antigens they possess. The surface structures are expressed as 0 (somatic, cellwall) antigens, which are lipopolysaccharides; K (capsular) antigens, which are polysaccharides; and H (flagellar) antigens, which are proteins (Fig. 1) . 10, 38 There are at least 150 recognized 0 antigens, 90 K antigens, and 50 H antigens. Each serotype is designated by the numbers of the antigens it carries-for example, 0139:K82:H2 (Table 1) 

For an ETEC strain to be an enteropathogenic E. coli (EPEC) strain capable of causing clinical disease, it must also be capable of adhering to the intestinal mucosa of the small intestine and proliferating to a dense population (in excess of 10 8 per 5 cm segment of intestine). This results in sufficient enterotoxin to stimulate intestinal villous hypersecretion, causing diarrhea. 32 Three adherence or colonizing factors have been identified on EPEC of calves, lambs, and pigs. They are pili (fimbriae), which are plasmidmediated, hairlike projections on the surface of the bacteria (Figs. 1 and 2) . These pili have been identified as the K88, K99, and 987P antigens. All three occur on EPEC of piglets, whereas only the K99 pilus has been commonly identified on calf and lamb EPEC. 62 The common adhesion factor of calf and lamb EPEC, which was first reported in 1971, was identified as a pilus and designated the K99 antigen in 1975. 13 ,62 Pilus antigens behave serologically like capsular K polysaccharide antigens during serotyping, and some were designated as K antigens even though they were recognized as protein. 48 A new nomenclature has been suggested to eliminate the confusion between capsular K and pilus K antigens. Pilus antigens are to be identified by the letter F (K99 is now F5).50

Capsule A study in 1982 found that noncapsular mutants of an EPEC strain failed to colonize to large numbers in a calf's intestine and cause diarrhea.24 These results were consistent with earlier work that found the capsule of some EPEC strains was required for intestinal adhesion, colonization, and full expression of pathogenicity. 61, 71 It was thought that the K99 pili and capsule might act in concert to anchor the bacteria to intestinal villous epithelial cells. 24 Recently, it has been reported that most EPEC isolated from neonatal diarrheic calves had a type-A capsule, K99 pili, and produced ST. It was suggested that type-A capsular polysaccharide should also be considered a virulence factor of bovine EPEC.65 PATHOGENESIS Categories in the pathogenesis of diarrhea have been described as (1) hypermotility, (2) increased intestinal permeability, (3) hypersecretion, and (4) malabsorption. 46 Enteric colibacillosis is an example of a diarrheal disease resulting from intestinal hypersecretion. In this disease, the intestinal villi, along with their digestive and absorptive capabilities, remain intact. The intestinal crypts also remain intact; however, their secretion is apparently increased beyond the absorptive capacity of the villi so that diarrhea occurs. 47 Calves are most susceptible to intestinal colonization by EPEC immediately after birth. Age-related resistance to adhesion appears to develop in the first few days of the calf's life. 66 It has been demonstrated that prior or simultaneous rotavirus infection enables ETEC colonization of the intestine in older calves. 74 Adherence brings the bacteria into close association with the intestinal villous cells, allowing colonization, and facilitates the effect of enterotoxin on the secretory cells. 66 Heat-stable enterotoxin initiates a buildup of cyclic guanosine 3' ,5'monophosphate (cGMP) in gut secretory cells, which produces net secretion. Hypersecretion causes the loss of needed electrolytes, including bicarbonate, and fluid into diarrheic feces. 16 ,20 Dehydration and acidosis occur because of these losses, causing the clinical signs of enteric colibacillosis and possibly death.

The importance of colostrum consumption by neonatal calves for the prevention of scours was recognized as early as 1893. 44 Absorption of colostral antibodies occurs only during the first 24 hours of a calf's life. There is peak absorption at about 6 hours of age with a decrease to no absorptive capability by 24 hours of age. 4,5 Absorbed colostral antibodies are active systemically against septicemic colibacillosis. They also provide local immunity within the intestinal lumen to protect against the scours of enteric colibacillosis. 42 ,43,45 Colostral K99 antibodies are most protective if consumed previous to infection with EPEC. 41 Calves should consume about 50 ml per kg body weight of colostrum at the first feeding, and this should occur within 4 hours after birth for maximum absorption. 43 A second feeding of colostrum seems to increase the efficiency of antibody absorption from the first. 28 Consumption of colostral antibody should continue during the first 24 hours of life to maintain antibody with the intestine during the time that EPEC adhesion to the intestinal wall may occur. 36 Colstral K99 antibodies have little effect once diarrhea has commenced; they are principally prophylactic in action. A recent study showed that K99 antibodies consumed up to 3 hours after oral challenge with EPEC were protective against enteric colibacillosis. These antibodies consumed 4 hours after challenge allowed disease to occur in most calves, with a 40 per cent mortality rate. After a 5-hour delay, there was no protective effect provided by the antibodies. 75

Before the pathogenesis of bovine enteric colibacillosis had been determined, there were many requests by veterinary practitioners for diagnostic laboratories to produce autogenous bacterins for use in problem cattle and swine herds. Efficacy reports on these products were variable. There were reports of protection in uncontrolled trials,21,22,64 protection in partially controlled trials,53,58 and no protection in controlled trials, 18, 37, 67 o Antigen Vaccines There was evidence that calves receiving colostral antibodies to certain strains of E. coli were protected against those strains. 9 ,3O,31 It was determined, in 1961, that antibodies to the 0 antigens of a strain had little protective effect if that strain possessed a capsule. 13 A study in 1978 found that antibodies to the cell-wall antigen did not protect against diarrheic disease in the absence of antibodies to the capsular K antigen of the challenge strain. 54 

Studies in 1961 reported that antibody to the polysaccharide capsular antigen was the main protective antibody against EPEC. 13 Many different capsular antigens were recognized on such strains of the bacteria. Colostral antibodies to the specific capsular antigen of the challenge strain have been shown to protect neonatal calves from enteric colibacillosis. 54 ,55,59 Enterotoxin Vaccines ETEC enterotoxin (ST) alone is not antigenic. 21 Studies using ST conjugated to porcine immunoglobulin (IgG) for immunization of rats demonstrated enterotoxin-neutralizing activity when ligated intestinal loops were challenged with enterotoxin. 39 ,4O In contrast, in an investigation in which sows were vaccinated with ST -bovine IgG conjugate, the mortality of piglets suckled on immunized sows was not much different from that of piglets nursed on unimmunized sows. 49

In a 1975 Montana study, certain strains of E. coli were found to be prevalent in calves with diarrheic disease. In a controlled field trial using 23 herds (3508 cows) with histories of acute calf diarrhea, significantly fewer calves of cows vaccinated with the six-strain E. coli bacterin died of diarrheic disease than did calves of control cows. There was, however, marked interherd variation in efficacy. 57 A four-strain E. coli bacterin was used in 1980 investigations to evaluate its ability to elicit passive immunity in calves of vaccinated cows. Strain B41 (0101:K-:K99) was used as the source ofK99 antigen. Three other serogroups (0101:K30:K99, 09:K35:K99, 08:K85:K99) were also used because their capsular antigens were found on 90 per cent of the isolates of ETEC from diarrheic calves in Montana. 56 These same three capular antigens were also commonly associated with epizootics of neonatal calf enteric colibacillosis from other areas. 24 ,58 In a challenge study, all 21 calves nursing vaccinated dams were protected from acute enteric colibacillosis, whereas 14 of20 calves nursing control dams developed the disease. In 12 privately owned herds with histories of naturally occurring diarrheic disease, significantly fewer calves nursing vaccinated dams died of enteric disease than did calves nursing control dams. There was considerable interherd variability in efficacy, which could be expected because of the variety of infectious agents, environmental conditions, and management factors that can contribute to occurrence of calf diarrhea. 56

Because a variety of different capsular antigens have been shown to occur on EPEC affected calves, a vaccine based on these antigens would have to control multiple capsular antigens to provide protection against a wide variety of EPEC strains. l An alternate approach is to produce immunity to a common antigen possessed by many different EPEC strains. The plasmid-mediated K99 pilus antigen was the logical choice because it has been recognized as the common antigen on calf and lamb EPEC since its identification in 1975. 63 It also plays a vital role in the pathogenesis of bovine enteric colibacillosis by allowing EPEC to adhere to the intestinal mucosa and proliferate to abnormally high numbers. 58 ,63 Colostral antibodies from cows vaccinated with whole cell bacterins containing the K99 antigen l ,26 or purified K99 antigen l ,2,1l,l2,60,73 have been shown to protect calves from enteric colibacillosis via lacteal immunity. Recently, pili different from K99 have been reported to exist on calf and lamb EPEC.l2,29,52

With the use of cow-directed vaccines, precalving cows must be handled twice the first year and boostered once annually to obtain adequate levels of colostral immunity.27 Also, the occurrence of enteric colibacillosis varies from herd to herd and year to year. This is because the epizootology of the disease includes a variety of meteorologic, environmental, and management factors. These concerns have prompted investigations for techniques of direct oral, passive immunization of the calf against EPEC that can be used before or after the beginning of an outbreak of enteric colibacillosis.

Recently, a mouse hybridoma-derived monoclonal antibody (MCA) to the K99 antigen has been developed and evaluated in experimental challenge studies. When the MCA was administered orally to both colostrum-fed and colostrum-deprived neonatal calves, the mortality rate after challenge with virulent EPEC was significantly reduced when compared with control calves (p less than 0.001). Furthermore the severity of clinical disease was also significantly reduced in calves receiving oral K99 specific M CA. 68 

Vaccines are only part of a total management program necessary for the prevention of enteric colibacillosis and other calf scours. Pregnant cows must be provided a proper level of nutrition to be in good condition at calving and to be capable of producing an adequate quantity of quality colostrum for their calves. The calving site should be clean, free of infection, and provide good footing and shelter during inclement weather. Crowding and stress should be avoided in the maternity area. If several calving pens are available, this will allow for vacating, cleaning, and disinfecting before another cow is put in the pen, especially if a calf has scoured in that pen. The pregnant cow should be observed closely to ensure that all goes well during the birth of her calf. Immediately after birth, the calf's navel should be dipped in iodine or teat-dip solution. At this time, the herdsman should ensure that the calf nurses and gets a good fill of colostrum. Monoclonal K99 antibody should be available for use if an outbreak occurs, especially with unvaccinated cow herds.

Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins

Vaccination of cows with purified K99 antigen, K99 + anucleated live E. coli, and whole cell bacterins containing enterotoxigenic E. coli for prevention of enterotoxigenic colibacillosis of calves

Acute undifferentiated neonatal diarrhea in beef calves 1. Occurrence and distribution of infectious agents

Acceleration of the absorption of unchanged globulins in the newborn calf by factors in colostrum

The specificity of the intestinal absorption of large molecules by the newborn calf

Bovine cryptosporidiosis in the north central United States

Veterinary Medicine. Edition 5. Philadelphia, Lea & Febiger

Biochemical characteristics of enterotoxigenic and nonenterotoxigenic Escherichia coli isolated from calves with diarrhea

Nutritive value of colostrum for the calf. 7. Observations on the nature of the protective properties of colostrum

Specific protection by colostrum from cows vaccinated with the K99 antigen in newborn calves experimentally infected with E. coli ent. K99

Vaccination contre l'antigene K99 et d'autres "adhesines" des Escherichia coli bovins

The relationship of virulence and K antigen in Escherichia coli

Enzyme-linked immunosorbent assay for diagnosis of rotavirus infections in calves

Diagnosis of bovine coronavirus infections with hemadsorption-elution-hemagglutination assay

Heat-stable enterotoxin of Escherichia coli: Invitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine

Diagnosis of colibacillosis

Studies on colibacillosis of calves

Suckling mouse model for detection of heat stable Escherichia coli enterotoxin: Characteristics of the model

Effect of purified Escherichia coli heat-stable enterotoxin on intestinal cyclic nucleotide metabolism and fluid secretion

Hagan and Brunner's Infectious Diseases of Domestic Animals

Escherichia coli isolated from dams and their calves: Bacteriologic and serologic test results

Colibacillosis of calves in Ontario. II. Association of certain serotypes of Escherichia coli with calf scours

Detection of bovine enteropathogenic Escherichia coli by direct fluorescent antibody technique

The role of K antigens of enteropathogenic Escherichia coli in colonization of the small intestine of calves

Evaluation of an Escherichia coli bacterin for preventing bovine neonatal enteric colibacillosis

Efficacy of a single annual booster inoculation of cows with Escherichia coli bacterin for preventing enteric colibacillosis in neonatal calves

Passive immunity in the lamb. Effects of a second feed of colostrum on antibody absorption from the first feed

Controlling colibacillosis in neonatal calves

Bacterium coli antibodies in colostrum and their relation to calf survival

Further observations on the significance of colostrum for the calf. 11. The immunological importance of colostrum

Distribution and virulence of Escherichia coli in the small intestine of calves with and without diarrhea

Escherichia coli in the small intestines of calves with and without diarrhea: Identification of virulence factors

Some observations on infection with Bacterium coli through the alimentary canal in newborn calves

Ueber die Kalberruhr und deren Aetiologie

Resistance of neonatal calves given colostrum diet to oral challenge with a septicemia-producing E. coli

The evaluation oflive and dead Escherichia coli vaccines administered to the pregnant female in the prevention of scouring (diarrhoea) in piglets

The serology of the Coli group

Protection in rats immunized with Escherichia coli heat stable enterotoxin

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development

Studies on the immunity of the calf to colibacillosis. VII. The experimental reproduction of enteric colibacillosis in colostrumfed calves

Studies on the immunity of the calf to colibacillosis. II

Studies on immunity of the calf to colibacillosis

Intestinal diseases of young calves with special reference to infection with Bacterium coli

Observations on the immune globulin levels of neonatal calves and their relationship to diseases

Mechanisms in the pathogenesis of diarrhea: A review

Pathogenesis of enteric diseases caused by Escherichia coli

Pili as protective antigens in vaccines for the control of enterotoxigenic Escherichia coli infections

Immunization of swine with heat-stable Escherichia coli enterotoxin coupled to carrier protein does not protect suckling pigs against an Escherichia coli strain that produces heat-stable enterotoxin

Prevalence of pilus antigens, enterotoxin types, and enteropathogenicity among K88-negative enterotoxigenic Escherichia coli from neonatal pigs

R: Pathological and microbiological observations made on spontaneous cases of acute neonatal calf diarrhea

Adhesion in vitro and in vivo associated with an adhesive antigen (F41) produced by a K99 mutant of the reference strain E. coli B41

Characterization of Escherichia coli obtained from newborn calves with diarrhea

Enteric colibacillosis in calves: Immunogenicity and antigenicity of Escherichia coli antigens

Passive protection of calves against enteric colibacillosis by vaccination of their dams with capsular and fimbrial K antigens of Escherichia coli

Passive protection of calves against experimentally induced and naturally occurring enteric colibacillosis

Vaccination of cows with an Escherichia coli bacterin for the prevention of naturally occurring diarrheal disease

Occurrence and characteristics of enterotoxigenic Escherichia coli isolated from calves with diarrhea

Passive immunization of calves against experimentally induced enteric colibacillosis by vaccination of dams

Vaccination of cows with a K99 extract to protect newborn calves against experimental enterotoxic colibacillosis

Colonization of porcine small intestine by Escherichia coli strains. Ileal colonization and adhesion by pig enteropathogens which lack K88 antigen and by some capsular mutants

Serology of Escherichia coli fimbriae

The establishment of K99, a thermolabile, transmissible Escherichia coli K antigen, previously called "Kco," possessed by calf and lamb enteropathogenic strains

Studies on Escherichia coli of animal origin. I. E. coli from natural outbreaks of colibacillosis of calves

Interest of slide agglutination test of A antigen for the detection of enteropathogenic strains of Escherichia coli in diarrheric calves

Development of resistance with host age to adhesion of K99 + Escherichia coli to isolated intestinal epithelial cells

The evaluation of a dead Escherichia coli vaccine administered during pregnancy in the prevention of scouring (diarrhoea) in calves

Protection of calves against fatal enteric colibacillosis by orally administered Escherichia coli K99 specific monoclonal antibody

Studies on pathogenic bacteria from bovine sources. II. Mutations and their immunolOgical significance

Observations by the ligated intestinal segment and oral inoculation methods on Escherichia coli infection in pigs, calves, lambs, and rabbits

The influence of plasmid-determined and other characteristics of enteropathogenic Escherichia coli on their ability to proliferate in the elementary tracts of piglets, calves and lambs

Further observations on Escherichia coli enterotoxins with particular regard to those produced by atypical piglet strains and by cow and lamb strains: The transmissible nature of these enterotoxins and of a K antigen possessed by calf and lamb strains

Passive immunity in calf diarrhea: Vaccination with K99 antigen of enterotoxigenic Escherichia coli and rotavirus

Interaction of rota virus and enterotoxigenic Escherichia coli in conventionally reared dairy calves

Oral immunization of young calves against enteropathogenic E. coli

The aetiology and diagnosis of calf diarrhea